Search Results - "Økern, G"
-
1
Selective Ex Vivo T-Cell Expansion Using Next Generation Expansion DynabeadsTM Technology
Published in Cytotherapy (Oxford, England) (01-06-2016)Get full text
Journal Article -
2
Optimized Process for Regulatory T Cell Activation and Expansion Using Dynabeads™ Treg CD3/CD28 for Clinical Applications
Published in Cytotherapy (Oxford, England) (01-06-2016)Get full text
Journal Article -
3
Immunotherapy: NOVEL ISOLATION AND ACTIVATION PLATFORM WITH ACTIVE-RELEASE TECHNOLOGY FOR SCALABLE CELL THERAPY MANUFACTURING
Published in Cytotherapy (Oxford, England) (01-05-2023)Get full text
Journal Article -
4
1058 - Immunotherapy: NOVEL ISOLATION AND ACTIVATION PLATFORM WITH ACTIVE-RELEASE TECHNOLOGY FOR SCALABLE CELL THERAPY MANUFACTURING
Published in Cytotherapy (Oxford, England) (01-05-2023)Get full text
Journal Article -
5
Leveraging single-domain antibodies and magnetic bead technology to improve manufacturing of T-cells for cell therapies
Published in Cytotherapy (Oxford, England) (01-05-2021)Get full text
Journal Article -
6
-
7
164 - Optimized Process for Regulatory T Cell Activation and Expansion Using Dynabeads™ Treg CD3/CD28 for Clinical Applications
Published in Cytotherapy (Oxford, England) (01-06-2016)Get full text
Journal Article -
8
161 - Selective Ex Vivo T-Cell Expansion Using Next Generation Expansion DynabeadsTM Technology
Published in Cytotherapy (Oxford, England) (01-06-2016)Get full text
Journal Article -
9
Xeno-free serum replacement supplement for ex vivo culture and expansion of T cells
Published in Cytotherapy (Oxford, England) (01-04-2014)Get full text
Journal Article -
10
Xeno-free serum replacement supplement for ex vivo culture and expansion of T cells
Published in Cytotherapy (Oxford, England) (2014)Get full text
Journal Article